Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA Suggests Legislation To Streamline Enforcement In Supplement Market

Oct 21 2019

• By Eileen Francis and Malcolm Spicer

RulesRegulationsBooks_1200x675

Related Content

Opioid Approvals: Congress Wants US FDA Guidance On Abuse Potential

Oct 01 2018

Safe Level For CBD As Dietary Ingredient? FDA Continues Data Review

Sep 13 2019

Modernizing FDA's Supplement Industry Regulation Mapped Out In Five-Point Plan

Feb 12 2019

VMS Industry Wants Into CBD Market, Plus Enforcement On Firms Already There

Jun 04 2019

FDA Road To Decision On Expanding CBD Uses Starts With Weighing Impact On Existing And Future Use As Drug

Jun 03 2019

FDA Regulatory Oversight No Impediment To Drug-Spiked Supplements, Study Finds

Oct 12 2018

Additional Topics

International United States Dietary Supplements FDA Legislation Advertising, Marketing & Sales Business Strategies Commercial Companies Compliance Distribution E-Commerce Ingredients Enforcement Manufacturing Policy Recalls Regulation Safety Consumer

More from Regulation

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window